Use Your Perch To Get Media Exposure
All businesses occupy a perch. By that, I mean the manner in which their business operates throws off data that sheds light on their industry, competitors, suppliers or customers. Here’s some examples: • The number of times men click the profiles of fair-haired women on match.com answers the question whether or not gentleman do prefer blonds. Similarly
Generals Don’t Inspect The Bullets
As the content arms race rolls on, I’m beginning suspect that some CMOs are getting off track in their approach to content marketing. Too much oversight. Too much strategy. Too much handwringing. In my experience, the primary value of content marketing is catching a prospect at the moment they happen to be searching for the product
What Might Happen in 2016
Twitter will be acquired. Wall Street loves a good story, but it hates losses. With half a billion in losses in 2014, and the company on track to lose more this year than last, somebody is going to pull the plug. Parenthetical prediction: Twitter CEO Jack Dorsey will not survive the year and focus on
From Unicorn To Unicorpse In 12 Painful Steps
My client was a unicorn way back in 2008, before the present day meaning of the word was repurposed to mean private companies valued at more than $1 billion. Last time I checked, the company was worth about $10 million, a stunning loss of 99% of the company’s value. Here’s how the company’s 12 step ascent and descent went:
A Christmas Story
Just a few weeks before Christmas, I was a volunteer at a holiday party for underprivileged children. Underprivileged isn’t my word. To get to the party they had to be identified as ‘at risk’ by their teachers. I was helping my friend Carol who had been a volunteer at the event for several years and
The Spouting Whale Gets Harpooned
With his high profile arrest and perp walk this morning, Martin Shkreli has a massive public relations problem on his hands. As the photo demonstrates, the full force of the law is lined up against him. Mr. Shkreli is the hedge fund manager turned pharmaceutical entrepreneur who provoked outrage when his Turing Pharmaceuticals increased the
50 Questions Your Business Plan Should Answer
Sadly, most investors don’t read business plans. However, writing one is the only way you will be able to answer the following 50 questions you will be asked before investors show up to the closing table. 1. What is the price of your product or service and why? 2. How much capital is required to execute
APPL In, T Out & The Remains of the Day
In March of this year, Apple Inc. was added to the elite, 30-member Dow Jones Industrial Index, and AT&T was unceremoniously removed. In their press release, S&P Dow Jones Indices, said “The timing of Apple’s addition to the DJIA hinged on two stock splits: Apple’s 7:1 last June and Visa’s 4:1 on March 19th this
Pfizer: Representation Without Taxation
Inversion sure is the right word for the Allergan/Pfizer deal. Because what got the colonists lathered up enough to fight a war against the one global super power at the time was taxation without representation. Somehow that idea got turned on its head, and now one of the largest drug companies in America wants the